doi:10.16150/j.1671-2870.2022.04.001

Abstract

CLC Number:

R715.2

References 50

[1]	Williamson PR, Jarvis JN, Panackal AA, et al. Cryptococcal meningitis: epidemiology, immunology, diagnosis and therapy[J]. Nat Rev Neurol, 2017, 13(1):13-24. doi: 10.1038/nrneurol.2016.167 pmid: 27886201
[2]	中华医学会感染病学分会艾滋病丙型肝炎学组, 中国疾病预防控制中心. 中国艾滋病诊疗指南(2021年版)[J]. 中国艾滋病性病, 2021, 27(11):1182-1201.
	AIDS and hepatitis C group, infectious diseases branch, Chinese Medical Association, China Center for Disease Control and prevention. China AIDS diagnosis and treatment guide(2021 Edition)[J]. Chin J AIDS & STD, 2021, 27(11):1182-1201.
[3]	Sloan DJ, Parris V. Cryptococcal meningitis: epidemiology and therapeutic options[J]. Clin Epidemiol, 2014, 6:169-182. doi: 10.2147/CLEP.S38850 pmid: 24872723
[4]	Park BJ, Wannemuehler KA, Marston BJ, et al. Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS[J]. AIDS, 2009, 23(4):525-530. doi: 10.1097/QAD.0b013e328322ffac pmid: 19182676
[5]	Jarvis JN, Tenforde MW, Lechiile K, et al. Evaluation of a novel semiquantitative cryptococcal antigen lateral flow assay in patients with advanced HIV disease[J]. J Clin Microbiol, 2020, 58(9):e00441-20.
[6]	Rajasingham R, Smith RM, Park BJ, et al. Global burden of disease of HIV-associated cryptococcal meningitis: an updated analysis[J]. Lancet Infect Dis, 2017, 17(8):873-881. doi: S1473-3099(17)30243-8 pmid: 28483415
[7]	Toborek M, Lee YW, Flora G, et al. Mechanisms of the blood-brain barrier disruption in HIV-1 infection[J]. Cell Mol Neurobiol, 2005, 25(1):181-199. pmid: 15962513
[8]	Kanmogne GD, Schall K, Leibhart J, et al. HIV-1 gp120 compromises blood-brain barrier integrity and enhances monocyte migration across blood-brain barrier: implication for viral neuropathogenesis[J]. J Cereb Blood Flow Metab, 2007, 27(1):123-134. doi: 10.1038/sj.jcbfm.9600330 URL
[9]	Maziarz EK, Perfect JR. Cryptococcosis[J]. Infect Dis Clin North Am, 2016, 30(1):179-206. doi: 10.1016/j.idc.2015.10.006 URL
[10]	Zhao H, Zhou M, Zheng Q, et al. Clinical features and outcomes of cryptococcemia patients with and without HIV infection[J]. Mycoses, 2021, 64(6):656-667. doi: 10.1111/myc.13261 pmid: 33609302
[11]	Wake RM, Britz E, Sriruttan C, et al. High cryptococcal antigen titers in blood are predictive of subclinical cryptococcal meningitis among human immunodeficiency virus-infected patients[J]. Clin Infect Dis, 2018, 66(5):686-692. doi: 10.1093/cid/cix872 pmid: 29028998
[12]	Robertson EJ, Najjuka G, Rolfes MA, et al. Cryptococcus neoformans ex vivo capsule size is associated with intracranial pressure and host immune response in HIV-associated cryptococcal meningitis[J]. J Infect Dis, 2014, 209(1):74-82. doi: 10.1093/infdis/jit435 pmid: 23945372
[13]	Antinori S. New Insights into HIV/AIDS-Associated Cryptococcosis[J]. ISRN AIDS, 2013, 2013:471363.
[14]	Xu L, Xu Y, Zheng Y, et al. Differences in cytokine and chemokine profiles in cerebrospinal fluid caused by the etiology of cryptococcal meningitis and tuberculous meningitis in HIV patients[J]. Clin Exp Immunol, 2021, 206(1):82-90. doi: 10.1111/cei.13644 pmid: 34287847
[15]	Xu L, Guo Y, Zhao Y, et al. Chemokine and Cytokine cascade caused by skewing of the Th1-Th2 balance is associated with high intracranial pressure in HIV-associa-ted cryptococcal meningitis[J]. Mediators Inflamm, 2019, 2019:2053958.
[16]	Jiang YK, Wang RY, Zhou LH, et al. Cerebrospinal fluid cytokine and chemokine patterns correlate with prognosis of HIV-uninfected cryptococcal meningitis: A prospective observational study[J]. Front Immunol, 2022, 13:993495.
[17]	刘正印, 王贵强, 朱利平, 等. 隐球菌性脑膜炎诊治专家共识[J]. 中华内科杂志, 2018, 57(5):317-323. pmid: 29747285
	Liu ZY, Wang GQ, Zhu LP, et al. Expert consensus on the diagnosis and treatment of cryptococcal meningitis[J]. Chin J Intern Med, 2018, 57(5):317-323. doi: 10.3760/cma.j.issn.0578-1426.2018.05.003 pmid: 29747285
[18]	Xu L, Yu J, Zheng B, et al. HIV infection does not increase 10-week mortality of Chinese cryptococcal meningitis patients[J]. AIDS Res Hum Retroviruses, 2020, 36(9):734-741. doi: 10.1089/aid.2020.0001 URL
[19]	Rajasingham R, Wake RM, Beyene T, et al. Cryptococcal Meningitis diagnostics and screening in the era of point-of-care laboratory testing[J]. J Clin Microbiol, 2019, 57(1):e01238-18.
[20]	Boulware DR, Rolfes MA, Rajasingham R, et al. Multisite validation of cryptococcal antigen lateral flow assay and quantification by laser thermal contrast[J]. Emerg Infect Dis, 2014, 20(1):45-53. doi: 10.3201/eid2001.130906 pmid: 24378231
[21]	潘孝彰, 卢洪洲, 沈银忠. 冀望病原微生物的诊断有更大发展[J]. 诊断学理论与实践, 2010, 9(6):541-544.
	Pan XZ, Lu HZ, Shen YZ. Prospects on advances in diagnosis of pathogenic microorganisms[J]. J Diagn Concepts & Pract, 2010, 9(6):541-544.
[22]	“十三五”国家科技重大专项艾滋病机会性感染课题组. 艾滋病合并隐球菌病临床诊疗的专家共识[J]. 西南大学学报(自然科学版), 2020, 42(7):1-19.
	AIDS-Associated Opportunistic Infections Research Group of the National Science and Technology Marjor Project of China During the 13th Fiver-Year Plan Period. Expert consensus on the diagnosis and treatment of cryptococcosis in AIDS patients[J]. J Southwest Univ(Nat Sci), 2020, 42(7):1-19.
[23]	Tang MW, Clemons KV, Katzenstein DA, et al. The cryptococcal antigen lateral flow assay: A point-of-care diagnostic at an opportune time[J]. Crit Rev Microbiol, 2016, 42(4):634-642. doi: 10.3109/1040841X.2014.982509 pmid: 25612826
[24]	Perfect JR, Bicanic T. Cryptococcosis diagnosis and treatment: What do we know now[J]. Fungal Genet Biol, 2015, 78:49-54. doi: 10.1016/j.fgb.2014.10.003 pmid: 25312862
[25]	Gushiken AC, Saharia KK, Baddley JW. Cryptococcosis[J]. Infect Dis Clin North Am, 2021, 35(2):493-514. doi: 10.1016/j.idc.2021.03.012 URL
[26]	Wilson MR, Sample HA, Zorn KC, et al. Clinical metagenomic sequencing for diagnosis of meningitis and encephalitis[J]. N Engl J Med, 2019, 380(24):2327-2340. doi: 10.1056/NEJMoa1803396 URL
[27]	Chiu CY, Miller SA. Clinical metagenomics[J]. Nat Rev Genet, 2019, 20(6):341-355. doi: 10.1038/s41576-019-0113-7 pmid: 30918369
[28]	Gu W, Miller S, Chiu CY. Clinical metagenomic next-generation sequencing for pathogen detection[J]. Annu Rev Pathol, 2019, 14:319-338. doi: 10.1146/annurev-pathmechdis-012418-012751 pmid: 30355154
[29]	WHO Guidelines Approved by the Guidelines Review Committee. Guidelines for The Diagnosis, Prevention and Management of Cryptococcal Disease in HIV-Infected Adults, Adolescents and Children: Supplement to the 2016 Consolidated Guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection[M]. Geneva: World Health Organization, 2018.
[30]	Perfect JR, Dismukes WE, Dromer F, et al. Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of america[J]. Clin Infect Dis, 2010, 50(3):291-322. doi: 10.1086/649858 pmid: 20047480
[31]	Jarvis JN, Lawrence DS, Meya DB, et al. Single-dose liposomal amphotericin B treatment for cryptococcal meningitis[J]. N Engl J Med, 2022, 386(12):1109-1120. doi: 10.1056/NEJMoa2111904 URL
[32]	Temfack E, Boyer-Chammard T, Lawrence D, et al. New insights into cryptococcus spp. biology and cryptococcal meningitis[J]. Curr Neurol Neurosci Rep, 2019, 19(10):81. doi: 10.1007/s11910-019-0993-0 URL
[33]	WHO Guidelines Approved by the Guidelines Review Committee. Guidelines for Diagnosing, Preventing and Managing Cryptococcal Disease Among Adults, Adolescents and Children Living with HIV[M]. Geneva: World Health Organization, 2022.
[34]	Xu L, Tao R, Wu J, et al. Short-course rather than low-dose amphotericin B may exert potential influence on mortality in cryptococcal meningitis patients treated with amphotericin B plus flucytosine alone or in combination with fluconazole[J]. Front Microbiol, 2019, 10:2082. doi: 10.3389/fmicb.2019.02082 pmid: 31551999
[35]	Jarvis JN, Bicanic T, Loyse A, et al. Determinants of mortality in a combined cohort of 501 patients with HIV-associated cryptococcal meningitis: implications for improving outcomes[J]. Clin Infect Dis, 2014, 58(5):736-745. doi: 10.1093/cid/cit794 pmid: 24319084
[36]	Zhou Y, Yang Z, Liu M, et al. Independent risk factors for deaths due to AIDS in Chongqing, China: Does age matter?[J]. Front Med (Lausanne), 2021, 7:586390.
[37]	Wu L, Xiao J, Song Y, et al. The clinical characteristics and outcome of cryptococcal meningitis with AIDS in a tertiary hospital in China: an observational cohort study[J]. BMC Infect Dis, 2020, 20(1):912. doi: 10.1186/s12879-020-05661-9 pmid: 33261581
[38]	Chen J, Zhang R, Shen Y, et al. Serum cryptococcal antigen titre as a diagnostic tool and a predictor of mortality in HIV-infected patients with cryptococcal meningitis[J]. HIV Med, 2019, 20(1):69-73. doi: 10.1111/hiv.12679 pmid: 30311440
[39]	Nussbaum JC, Jackson A, Namarika D, et al. Combination flucytosine and high-dose fluconazole compared with fluconazole monotherapy for the treatment of cryptococcal meningitis: a randomized trial in Malawi[J]. Clin Infect Dis, 2010, 50(3):338-344. doi: 10.1086/649861 pmid: 20038244
[40]	Jarvis JN, Harrison TS. HIV-associated cryptococcal meningitis[J]. AIDS, 2007, 21(16):2119-2129. doi: 10.1097/QAD.0b013e3282a4a64d pmid: 18090038
[41]	Yao Y, Zhang JT, Yan B, et al. Voriconazole: a novel treatment option for cryptococcal meningitis[J]. Infect Dis(Lond), 2015, 47(10):694-700.
[42]	Theuretzbacher U, Ihle F, Derendorf H. Pharmacokinetic/pharmacodynamic profile of voriconazole[J]. Clin Pharmacokinet, 2006, 45(7):649-663. pmid: 16802848
[43]	陶然, 师金川, 郭永征, 等. 两性霉素B去氧胆酸盐、两性霉素B脂质体和伏立康唑诱导治疗HIV相关性隐球菌脑膜炎的效果比较[J]. 新发传染病电子杂志, 2019, 4(2):97-102.
	Tao R, Shi JC, Guo YZ, et al. Comparison of amphotericin B deoxycholate, amphotericin B liposome and voriconazole as induction treatment on HIV-related cryptococcal meningitis[J]. Electron J Emerg Infect Dis, 2019, 4(2):97-102.
[44]	Murphy RA, Hatlen TJ, Moosa MS. High-dose fluconazole consolidation therapy for cryptococcal meningitis in sub-saharan Africa: much to gain, little to lose[J]. AIDS Res Hum Retroviruses, 2018, 34(5):399-403. doi: 10.1089/aid.2017.0240 URL
[45]	Rolfes MA, Rhein J, Schutz C, et al. Cerebrospinal fluid culture positivity and clinical outcomes after amphotericin-based induction therapy for cryptococcal meningitis[J]. Open Forum Infect Dis, 2015, 2(4):ofv157. doi: 10.1093/ofid/ofv157 URL
[46]	Grinsztejn B, Hosseinipour MC, Ribaudo HJ, et al. Effects of early versus delayed initiation of antiretroviral treatment on clinical outcomes of HIV-1 infection: results from the phase 3 HPTN 052 randomised controlled trial[J]. Lancet Infect Dis, 2014, 14(4):281-290. doi: 10.1016/S1473-3099(13)70692-3 pmid: 24602844
[47]	Tao R, Xu L, Guo Y, et al. Ventriculoperitoneal shunt is associated with increased cerebrospinal fluid protein level in HIV-infected cryptococcal meningitis patients[J]. BMC Infect Dis, 2022, 22(1):286. doi: 10.1186/s12879-022-07286-6 pmid: 35351023
[48]	Shelburne SA 3rd, Darcourt J, White AC Jr, et al. The role of immune reconstitution inflammatory syndrome in AIDS-related cryptococcus neoformans disease in the era of highly active antiretroviral therapy[J]. Clin Infect Dis, 2005, 40(7):1049-1052. pmid: 15825000
[49]	Boulware DR, Meya DB, Muzoora C, et al. Timing of antiretroviral therapy after diagnosis of cryptococcal meningitis[J]. N Engl J Med, 2014, 370(26):2487-2498. doi: 10.1056/NEJMoa1312884 URL
[50]	Tao R, Peng X, Liu X, et al. Outcome of lenalidomide treatment for cognitive impairment caused by immune reconstitution inflammatory syndrome in patients with HIV-related cryptococcal meningitis[J]. J Inflamm Res, 2022, 15:5327-5336. doi: 10.2147/JIR.S374333 URL

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References 50

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	. [J]. Journal of Diagnostics Concepts & Practice, 2022, 21(04): 425-430.
[2]	HUANG Chen, JING Feng, YANG Zhitao, et al . Exploration and practice of construction of nursing management system in shelter hospital [J]. Journal of Diagnostics Concepts & Practice, 2022, 21(02): 286-290.
[3]	LIANG Jing, HUANG Chen, JIANG Yan, et al . Management strategy of nursing for prevention and control of COVID-19 in emergency infusion room [J]. Journal of Diagnostics Concepts & Practice, 2022, 21(02): 281-285.
[4]	ZHANG Hong, ZHU Mengmeng, et al . Safety nursing for eating in the elderly during the COVID-19 pandemic [J]. Journal of Diagnostics Concepts & Practice, 2022, 21(02): 277-280.
[5]	ZHOU Jianping, YANG Zhenhua, WANG Yichen, et al . Practice and thinking of the medical team of the elderly medical assistance center in the prevention and control of COVID-19 in Shanghai [J]. Journal of Diagnostics Concepts & Practice, 2022, 21(02): 265-269.
[6]	ZHA Qinghua, WANG Xiaoning, ZHANG Yin, et al . Exploration and practice of nucleic acid sampling outside hospital during the epidemic period of COVID-19 pandemic [J]. Journal of Diagnostics Concepts & Practice, 2022, 21(02): 229-233.
[7]	YU Ping, QIU Weiyu, WANG Xu, et al . Practice and exploration of drug security management in large shelter hospitals [J]. Journal of Diagnostics Concepts & Practice, 2022, 21(02): 221-224.
[8]	JIANG Yan, LIN Wei, HUANG Chen, et al . Exploration and practice of emergency supplies management mode in emergency department under COVID-19 pandemic [J]. Journal of Diagnostics Concepts & Practice, 2022, 21(02): 212-215.
[9]	TANG Jie, MA Longxin, CAO Qing, et al . Study on the construction of smart shelter hospital based on new generation information technology [J]. Journal of Diagnostics Concepts & Practice, 2022, 21(02): 196-204.
[10]	JIANG Yan, CHEN Ting, HUANG Chen, PAN Peiqian, JING Feng, et al . Construction and practice of emergency response capability training program for all staff in emergency medical ward under COVID-19：Emergency response strategy [J]. Journal of Diagnostics Concepts & Practice, 2022, 21(02): 189-195.
[11]	MENG Jun, JIN Peipei, CHEN Changqiang, CHEN Jiuming, FAN Zhenjia, CHEN Shikai, DAI Jing, et al . Emergency transformation experience of the laboratory department of a hospital designated for admission of patients with novel coronavirus infection in emergency conversion [J]. Journal of Diagnostics Concepts & Practice, 2022, 21(02): 184-188.
[12]	SHI Yingying, ZHONG Xu, LIU Jialin, HE Le, XIONG Shaoji, WENG Y, DING Chengwei, YANG Y, CHEN Weihon, QIU Liping, XIN Haiguang. Hospital infection prevention and control practices in anti-epidemic medical staff and workers during COVID-19 epidemic: investigation and countermeasures [J]. Journal of Diagnostics Concepts & Practice, 2022, 21(02): 178-183.
[13]	DING Ning, CHEN Shikai, MENG Jun, DAI Jing, JIN Peipei, et al . Correlation and influencing factors analysis of the cycle threshold value in detection of novel coronavirus nucleic acid(Omicron) and the negative conversion cycle in infected patients [J]. Journal of Diagnostics Concepts & Practice, 2022, 21(02): 169-173.
[14]	YANG Zhitao, CHEN Ying, JING Feng, XIE Zhihui, ZHANG Yibo, SHANG Hanbin, LIN Jingsheng, WU Wenjuan, GU Zhidong, BI Yufang, CHEN Erzhen. Practice and Exploration on the construction of medical affairs management system in large Fangcang hospitals [J]. Journal of Diagnostics Concepts & Practice, 2022, 21(02): 154-159.
[15]	CHEN Changqiang, MENG Jun, JIN Peipei, DAI Jing, et al . Practice and exploration of novel coronavirus nucleic acid detection in designated hospitals [J]. Journal of Diagnostics Concepts & Practice, 2022, 21(02): 143-149.